Stem Holdings (Stem Holdings) EBIT : $-3.93 Mil (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings EBIT?

Stem Holdings's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2023 was $2.33 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was $-3.93 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Stem Holdings's annualized ROC % for the quarter that ended in Sep. 2023 was 45.65%. Stem Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 140.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Stem Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -248.67%.

Stem Holdings EBIT Historical Data

The historical data trend for Stem Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings EBIT Chart

Stem Holdings Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT

Get a 7-Day Free Trial

-26.39

-9.06

-8.32

-2.16

-3.93

Stem Holdings Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBIT	Get a 7-Day Free Trial															2.66	-2.79	-2.64	-0.82	2.33

Competitive Comparison of Stem Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stem Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Stem Holdings's EV-to-EBIT falls into.

Stem Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.93 Mil.

Stem Holdings (OTCPK:STMH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Stem Holdings's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	8.596 * ( 1 - 0% )	/	( (25.057	+	12.607)	/ 2 )
=	8.596	/	18.832
=	45.65 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	25.684	-	2.739	-	( 1.704	-	max(0, 6.164	-	4.052	+	1.704	))
=	25.057

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	13.347	-	1.399	-	( 0.961	-	max(0, 13.978	-	13.319	+	0.961	))
=	12.607

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Stem Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	9.3	/	( ( (13.268 + max(-0.876, 0))	+	(0 + max(-0.58, 0)) )	/	2 )
=	9.3	/	( ( 13.268	+	0 )	/	2 )
=	9.3	/	6.634
=	140.19 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.267	+	1.303	+	0.395)	-	(2.739	+	0	+	0.102)
=	-0.876

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	11.058)	-	(1.399	+	0	+	10.239)
=	-0.58

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Stem Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2023 )
	=	-3.934	/	1.582
	=	-248.67 %

Stem Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Stem Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Stem Holdings (Stem Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

STEM:Canada

Address

2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431

Website

https://www.stemholdings.com

Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.

Executives

Matthew Cohen	director, officer: CEO & CFO	1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek	director	7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin	director	41ULUA PLACE, HAIKU HI 96708
Dennis Suskind	director	ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj	director	438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold	director	3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder	director	408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender	director	506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk	director, officer: President	9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard	director, officer: CFO	3496 FARIVIEW WAY, WEST LINN OR 97068